State of Wisconsin Investment Board raised its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 56.1% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 150,000 shares of the company’s stock after purchasing an additional 53,885 shares during the period. State of Wisconsin Investment Board owned 0.25% of HealthEquity worth $7,587,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of HQY. Teachers Advisors LLC boosted its stake in HealthEquity by 6.0% during the 1st quarter. Teachers Advisors LLC now owns 79,893 shares of the company’s stock valued at $3,391,000 after purchasing an additional 4,542 shares during the period. Dimensional Fund Advisors LP boosted its stake in HealthEquity by 38.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 377,919 shares of the company’s stock valued at $16,042,000 after purchasing an additional 104,960 shares during the period. Renaissance Technologies LLC acquired a new position in HealthEquity during the 1st quarter valued at about $1,426,000. Schwab Charles Investment Management Inc. boosted its stake in HealthEquity by 9.3% during the 1st quarter. Schwab Charles Investment Management Inc. now owns 180,474 shares of the company’s stock valued at $7,662,000 after purchasing an additional 15,414 shares during the period. Finally, Bank of America Corp DE boosted its stake in HealthEquity by 57.6% during the 1st quarter. Bank of America Corp DE now owns 86,183 shares of the company’s stock valued at $3,659,000 after purchasing an additional 31,500 shares during the period. 91.75% of the stock is owned by hedge funds and other institutional investors.

In related news, Director Frank Medici sold 700 shares of the business’s stock in a transaction that occurred on Wednesday, November 15th. The shares were sold at an average price of $51.05, for a total value of $35,735.00. Following the sale, the director now directly owns 6,381 shares in the company, valued at approximately $325,750.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Berkley Capital, Llc sold 23,479 shares of the business’s stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $51.08, for a total transaction of $1,199,307.32. The disclosure for this sale can be found here. Insiders sold a total of 1,587,770 shares of company stock worth $82,754,799 over the last quarter. Insiders own 29.00% of the company’s stock.

Shares of HealthEquity, Inc. (NASDAQ HQY) opened at $50.17 on Friday. The firm has a market cap of $3,034.73, a P/E ratio of 79.63, a PEG ratio of 2.20 and a beta of 1.77. HealthEquity, Inc. has a one year low of $37.62 and a one year high of $55.31.

HealthEquity (NASDAQ:HQY) last released its earnings results on Tuesday, September 5th. The company reported $0.27 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.13. HealthEquity had a net margin of 20.27% and a return on equity of 13.93%. The business had revenue of $56.90 million for the quarter, compared to the consensus estimate of $55.66 million. During the same period in the previous year, the firm earned $0.16 EPS. The business’s revenue for the quarter was up 28.7% on a year-over-year basis. research analysts predict that HealthEquity, Inc. will post 0.7 EPS for the current year.

A number of analysts have recently weighed in on the stock. BidaskClub lowered shares of HealthEquity from a “buy” rating to a “hold” rating in a research note on Monday, July 24th. Zacks Investment Research lowered shares of HealthEquity from a “buy” rating to a “hold” rating in a research note on Wednesday. TheStreet raised shares of HealthEquity from a “c” rating to a “b” rating in a research note on Monday, July 31st. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $56.00 price target on shares of HealthEquity in a research note on Tuesday, September 5th. Finally, Robert W. Baird reaffirmed a “hold” rating on shares of HealthEquity in a research note on Thursday, September 21st. Three investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $57.50.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/state-of-wisconsin-investment-board-has-7-59-million-holdings-in-healthequity-inc-hqy/1713637.html.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.